Effects on serotonergic neurotransmission underlie the clinical therapeutic effects of serotonin reuptake inhibitors (SSRIs), the class of drugs most frequently prescribed for the treatment of depression. Nevertheless, very little information is available about how SSRIs produce their behavioral effects. Research supported by this project examines the pharmacological and physiological basis underlying the antidepressant behavioral effects of SSRIs and other putative serotonergic antidepressants. The behavioral effects of antidepressant drugs are studied using the rat forced swimming test, a behavioral test that successfully predicts the clinical effects of antidepressant drugs. A version of the rat forced swimming test developed by this laboratory is used that measures the core response of immobility and component active behaviors and distinguishes antidepressants pharmacologically selective for serotonergic and catecholamine systems. The neurochemical effects of antidepressants and forced swimming are studied using in vivo microdialysis, which permits the release of 5-HT to be measured in discrete brain regions in awake unrestrained animals. The proposed research program will continue to investigate the neural substrates underlying the antidepressant behavioral effects of SSRIs. The first specific aim will characterize and distinguish the role of serotonin and catecholamine systems in the behavioral effects of an extended series of antidepressant drugs in the forced swimming test. Studies will also identify 5-HT receptor subtypes that are involved in the behavioral effects of SSRIs and that are likely to produce antidepressant effects. The second specific aim will employ the neurochemical depletion of 5-HT to establish the role of intact serotonergic neurons in the behavioral effects of different types of antidepressant drugs. Studies involving localized depletion of 5-HT will identify the brain regions likely to be associated with the production of their behavioral effects. The third specific aim will understand how the alterations of 5-HT release produced by acute stress in the forced swimming test, and modifications of 5-HT neurotransmission produced by antidepressant treatments, are related to the production of the behavioral effects of antidepressant drugs in this test. The results of the proposed work should have important implications for our understanding of the mechanisms involved in the behavioral effects of SSRIs in the clinical treatment of depression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH036262-20
Application #
6476975
Study Section
Special Emphasis Panel (ZRG1-IFCN-1 (01))
Program Officer
Winsky, Lois M
Project Start
1982-05-01
Project End
2003-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
20
Fiscal Year
2002
Total Cost
$257,098
Indirect Cost
Name
University of Pennsylvania
Department
Psychiatry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Cryan, John F; Page, Michelle E; Lucki, Irwin (2005) Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 182:335-44
Hoshaw, Brian A; Malberg, Jessica E; Lucki, Irwin (2005) Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 1037:204-8
Cryan, John F; Valentino, Rita J; Lucki, Irwin (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547-69
Cryan, John F; O'Leary, Olivia F; Jin, Sung-Ha et al. (2004) Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci U S A 101:8186-91
Page, Michelle E; Brown, Kevin; Lucki, Irwin (2003) Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action. Psychopharmacology (Berl) 165:194-201
Cryan, John F; Page, Michelle E; Lucki, Irwin (2002) Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol 436:197-205
Rittenhouse, Peter A; Lopez-Rubalcava, Carolina; Stanwood, Gregg D et al. (2002) Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology 27:303-18
Cryan, John F; Markou, Athina; Lucki, Irwin (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-45
Price, Michelle L; Kirby, Lynn G; Valentino, Rita J et al. (2002) Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology (Berl) 162:406-14
Cryan, J F; Dalvi, A; Jin, S H et al. (2001) Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 298:651-7

Showing the most recent 10 out of 56 publications